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Abstract
Background: It is widely acknowledged that there is a global divide on health care and health
research known as the 10/90 divide.
Methods: A retrospective survey of articles published in the BMJ, Lancet, NEJM, Annals of Internal
Medicine & JAMA in a calendar year to examine the contribution of the developing world to
medical literature. We categorized countries into four regions: UK, USA, Other Euro-American
countries (OEAC) and (RoW). OEAC were European countries other than the UK but including
Australia, New Zealand and Canada. RoW comprised all other countries.
Results: The average contribution of the RoW to the research literature in the five journals was
6.5%. In the two British journals 7.6% of the articles were from the RoW; in the three American
journals 4.8% of articles were from RoW. The highest proportion of papers from the RoW was in
the Lancet (12%). An analysis of the authorship of 151 articles from RoW showed that 104 (68.9%)
involved authorship with developed countries in Europe or North America. There were 15 original
papers in these journals with data from RoW but without any authors from RoW.
Conclusions: There is a marked under-representation of countries in high-impact general medical
journals. The ethical implications of this inequity and ways of reducing it are discussed.
Background
National and international bodies concerned with
research ethics need to confront the greatest ethical chal-
lenge-the enormous inequities in global health research
[1]. Thus, less than 10% of the world's research resources
are earmarked for 90% of the health problems [2].
Though 93% of the world's burden of preventable mortal-
ity occurs in developing countries, too little research fund-
ing is targeted to health problems in those countries [3].
This divide in research funding is mirrored by concerns
regarding a divide in the proportion of publications aris-
ing from medical research in developing countries. A
recent survey of six leading psychiatric journals revealed
that only 6% of the articles originated from, or described
data arising from, regions of the world that accounted for
over 90% of the global population [4]. Following this
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paper, the issue of under-representation of developing
countries was debated and discussed in many journals
and by journal editors [5-7].
The aim of this study is to investigate the publication bias
beyond the field of psychiatry to determine the overall
contribution of different regions of the world to the med-
ical literature published in high-impact journals and, in
particular, to quantify the developing world's
contribution.
Methods
The method used is the same as that which was used by
two of the authors (AS and VP) in a recent survey of the
international representation in the psychiatric literature
[4]. A retrospective survey was conducted of all issues in
one calendar year (the most recent, complete set available
in the medical library in Colombo where data collection
took place) of the following journals: BMJ, Lancet, NEJM,
Annals of Internal Medicine & JAMA. These journals were
selected because they have the highest impact amongst
general medical journals [8]. These journals lay claim to
their global legitimacy for many reasons: frequent publi-
cation, high impact, long history, credibility of the pub-
lisher, large numbers of full time editorial staff,
membership of the International Committee of Medical
Journal Editors, and influential joint statements [9]. The
year for which data was collected was 2000 for all jour-
nals, except JAMA for which it was 1999 (all issues in year
2000 were not available). All articles, excluding the speci-
fied ones in each journal were reviewed. In the BMJ we
excluded obituaries, multi-media, personal views, Min-
erva, news and soundings. In the Lancet we excluded Dis-
secting Room and news. In the Annals, we excluded on
Being a doctor, Current clinical issues, Medical writings,
Book notes, Ad Libitum and persona. In the NEJM, we
excluded book reviews, This week in the journal and
Abstracts. In JAMA, we excluded Medical news and Per-
spectives, Peace of my mind, JAMA hundred years ago,
Abstracts, FDA, CDC, poetry and medicines, Books jour-
nals, New media, World in medicine and the section titled
"from the JAMA websites". In the Lancet, editorials and
commentaries were pooled together, because the com-
mentaries in the Lancet resemble editorials in the other
journals in terms of their contents. None of the other four
journals had commentaries section.
For the allocation of regions of the world, we categorized
countries into four regions: UK, USA, OEAC (Other Euro-
American countries) and RoW (Rest of the World). OEAC
were European countries other than the UK but including
Australia, New Zealand and Canada. RoW comprised all
other countries including Eastern Europe, Central and
South America, Asia and Africa. We scrutinized each arti-
cle to examine the country of the authors' affiliation
address with a view to categorizing them into relevant
regions of the world. All authors were noted including
multiple authors in large multi-center studies. We also
scrutinized the methods section of all the original articles
to ascertain the origin of data with special emphasis on
whether the research was carried out in RoW countries.
The affiliation of the first, last and corresponding authors
was also noted. We worked with a negative bias against
the USA and the UK from where the journals originated.
Therefore articles, which included authors from the RoW,
were considered as arising from the RoW even if the first
author is from the UK, USA or OEAC. Similarly, articles
from the OEAC, which involved collaborations from the
UK or USA, were included in the OEAC category. In the
event of a collaborative study between the USA and the
UK, the allocation to region was based on the institutional
affiliation of the first author. The RoW category included
collaborative studies between any country in the RoW and
developed nations.
In some cases the origin of the author was difficult, partic-
ularly when there were two places named as their attached
institutions. For an example when one was in USA while
the other is in Kenya. We used our best guess in these
instances. For an example the two authors AS and VP in
this paper were based in RoW at the time we did this
research but were employed in UK but with strong affilia-
tions to the RoW countries where they were born and did
their research. Attempts to analyse the nationality of the
authors was therefore abandoned.
Results
The contribution of the RoW to the research literature sur-
veyed in these five high-impact journals was 6.5%. In the
two British journals, 7.6% of the articles were from the
RoW, whilst the proportion in the three American jour-
nals was 4.8%. This averages hides the fact that there is
considerable variation between journals; thus, around
3.5% of articles in the two journals of national medical
associations of the UK (BMJ) and USA (JAMA) were from
the RoW as compared to 12% in the Lancet articles (Table
1). Indeed, more than half the articles from the RoW were
published in just one journal, the Lancet (Table 2).
Within journals, variations in regional contributions from
other regions were also notable. Thus, the proportion of
articles from the UK was highest in the two journals pub-
lished in the UK (BMJ and Lancet) while the proportion
of articles from the USA was highest in the three journals
published in the USA. Table 2 shows the relative contribu-
tion of different regions of the RoW category to the total
number of editorials, original articles and reviews. Two
developed countries (Japan and Israel) contribute a fifth
of the literature from RoW, while the two most populous
countries in the world (India and China) contribute about
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13% together. A detailed analysis of the authorship of the
151 RoW articles showed that 104 (68.9%) involved col-
laborative authorship with developed countries in Europe
or North America; only 43 (31.1%) were entirely inde-
pendent efforts from the RoW.
There were 118 original papers with at least one author
from the RoW. Forty-five (38%) of them had a first author
from the RoW; 32 (27%) had a last author from the RoW;
and 36 (30%) had a corresponding author from the RoW.
Only 25 (21%) of them had first, last and corresponding
authors all from the RoW. There were 15 original papers
in these journals with data from the RoW but without any
authors from the RoW; of these 15, nine were in Lancet,
four in BMJ and one each in JAMA and NEJM. Thus, the
majority of the original articles originating from the RoW
had contribution from the developed world authors.
Discussion
This study presents findings of a survey of articles pub-
lished in five high-impact general medical journals with
the objective of describing the developing world's contri-
bution to research literature over a single calendar year.
Our way of classifying countries into developed (UK,
USA, OEAC) and developing countries (RoW) has obvi-
ous inadequacies but we followed the same method
adopted in an earlier paper [4]. Other euro-American
Table 1: The contribution of regions to the research literature in five leading journals
BMJ Lancet NEJM JAMA ANNALS Total
Editorials 261 3504 124 102 39 876
UK 160 61.4% 167 47.7% 10 8.0% 02 1.9% 01 2.4% 340 38.8%
USA 38 14.6% 87 24.9% 97 78.3% 97 95.0% 35 90.0% 354 40.4%
OEAC1 56 21.4% 89 25.4% 14 11.3% 02 1.9% 03 7.6% 164 18.7%
RoW2 07 2.6% 07 2.0 % 03 2.4% 01 0.9% 00 0.0% 18 2.6%
Original papers 322 307 218 227 115 1189
UK 216 67.0% 66 21.5 % 06 2.7% 04 1.8% 03 2.6% 295 24.8%
USA 22 7.0% 38 12.4% 107 49.1% 173 76.2% 81 70.4% 421 35.4%
OEAC 76 23.6% 136 44.3 % 78 35.8% 42 18.5% 23 20.0% 355 29.9%
RoW 08 2.4% 67 21.8% 27 12.4% 08 3.5% 08 7.0% 118 9.9%
Correspondence 1118 10435 894 605 251 3911
UK 829 74% 374 35.8% 30 3.4% 13 2.1% 04 1.6% 1250 32%
USA 69 6% 141 13.5% 601 67.2% 506 83.6% 183 72.9% 1500 38.4%
OEAC 174 16% 400 38.3% 212 23.7% 71 11.7% 49 19.5% 906 23.2%
RoW 46 4% 128 12.2% 51 5.7% 15 2.5% 15 6.0% 255 6.5%
Review articles 286 50 65 36 66 503
UK 195 68.2% 17 34% 04 6.2% 01 2.7% 01 1.6% 218 43.3%
USA 29 10.2% 15 30% 48 73.8% 28 78.0% 61 92.4% 181 36%
OEAC 54 18.8% 14 28% 13 20.0% 04 11.1% 04 6.0% 89 17.7%
RoW 08 2.8% 04 08% 00 0.0% 03 8.2% 00 0.0% 15 3%
Others3 47 208 149 145 27 576
UK 31 66.0% 68 32.8% 03 02.0% 00 00.0% 00 00.0% 102 17.7%
USA 08 17.0% 34 16.3% 118 79.3% 120 82.7% 25 92.6% 305 53%
OEAC 04 8.5% 78 37.5% 22 14.7 % 16 11.0% 01 3.7% 121 21%
RoW 04 8.5% 28 13.4% 06 4.0% 09 6.2% 01 3.7% 48 8.3%
Global total 2034 1958 1450 1115 498 7055
RoW total 73 3.6% 234 12% 87 6% 36 3.2% 24 4.8% 454 6.4 %
1. OEAC (Other Euro-American countries), OEAC were European countries other than the UK, Australia, New Zealand and Canada.
2. RoW comprised all other countries (i.e. all countries in Eastern Europe, Central and South America, Asia and Africa)
3. Others include: for The Lancet: case reports, view points, public letters, essays, public health, violence in health, department of medical history, 
the world, world ideas, health and human rights, development of ethics, eponymous, clinical picture, reportage, adverse drug reactions, personal 
papers, medicine and law, personal papers; for the JAMA: Patients relationships, grand rounds, clinical cross roads, rational clinical examinations, 
medicine and media, commentary, updates, letters from counters, public opinion and health, medical literature, health law and ethics, clinical cross 
roads; for the NEJM: images, clinical problem solving, case records from Massachusetts general hospital, clinical implications of basic research, 
sounding board, clinical problem solving, special articles, for the BMJ: drug point, practice and results, quality of life, history, practice point, lessons 
of every week; for the Annals: past present and future, time and medicine, social means of medicine, technology of time, personal time, media and 
publication, NIH conference, in the balance, abroad.
4. The Lancet had 52 editorials and 298 commentaries. Editorials were written in house.
5. The Lancet had 262 research letters. We did not include these either in the correspondence or with the Original papers category. Other 
journals did not have such a category to compare.
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countries (OEAC) shared many cultural and economic
features. Rest of the world (RoW) included Eastern
Europe, which although culturally related to Western
Europe was not economically on the same level, and
Japan, which was highly developed economically but did
not share many cultural factors with OEAC.
The key finding of our survey is that, only 6.5% of the
publications in these journals have authors from coun-
tries where 90% of the world's population lives. There is a
severe under representation of biomedical research from a
vast section of the world in these five journals. In addi-
tion, there are a small but significant number of articles
with data from the developing world without a single
author from these countries. This is a troublesome finding
that some would refer as 'safari research'. It is a separate
ethical issue and journal editors need to look at it
carefully.
The reasons for under representation of researchers based
in developing countries may include research barriers
such as lack of funding, poor facilities, limited technical
support and inadequate training. Many researchers from
developing countries do not speak English as their first
language. Fear of rejection by the journals, uncertainty
about which journal would be best to publish research, a
lack of the culture of publication, competing clinical com-
mitments, different ministry and donor driven agendas
for research, are some of the unseen barriers facing devel-
oping country researchers (10). The editors of leading
medical journals may not have paid sufficient attention to
these barriers, real and perceived, that clinical researcher
in developing countries face [11].
We acknowledge that many developing country research-
ers choose to publish their work in national or regional
journals that are not as high-impact as the journals we
have reviewed. However, many researchers, irrespective of
the country of their origin, also prefer to publish their
work in journals with a high impact factor and circulation.
This, inevitably, leads to a focus on leading journals pub-
lished from the UK or USA. However, journals may be
under some pressure to publish material, which is rele-
vant to the majority of their readership. Thus, it is not sur-
prising that journals from the UK have the majority of
articles from UK institutions and similarly, journals from
the USA tend to have most of their articles from US insti-
tutions. The BMJ admits that although the BMJ aspires to
be more international, they cannot forget that they reach
80% doctors in Britain [12]. However all these journals
are financially highly successful in global markets. Their
international success brings responsibilities to the global
community they serve and profits from [11].
Our findings are in agreement with other published find-
ings in this area [13]. In a study of randomised controlled
trials published in leading medical journals many of the
diseases afflicting the south are understudied [14]. Even in
the field of tropical medicine there were few contributions
originating from countries with a low human
development index (HDI) [15]. Another study, where the
number of biomedical articles were normalized to the
number of publications per million population, also
shows an under representation of Asia, Africa and South
America. The authors demonstrated that the number of
biomedical publications increase according to the eco-
nomic ranking of the country [16]. The same authors have
shown in a similar study that publications per million
population are more closely related to gross national
product (GNP) and research and development expendi-
ture [17]. The inescapable conclusion of this research is
that USA, UK and other European countries dominate
Table 2: Proportion of articles contributed by different regions of the RoW category to the total number of editorials, original articles 
and reviews.
BMJ Lancet NEJM JAMA Annals Total1(%)
India 2 1 2 0 0 05 (3)
China 2 5 6 1 1 15 (10)
Other Asian 6 8 3 2 0 19 (12)
Sub Saharan Africa 8 25 2 1 0 36 (24)
Latin America 2 11 4 5 2 24 (16)
Middle East/North Africa 0 6 1 0 0 07 (5)
Japan 0 8 5 0 4 17 (11)
Israel 3 6 4 1 0 14 (9)
Multi national 0 8 3 2 1 15 (10)
Total2 (%) 23 (15) 78 (52) 30 (20) 12 (8) 8 (5) 151
1 The % figures in this column represent the contribution of the specific country or region to the RoW papers in the table
2 The % figures in this row represent the contribution of the specific journal to the total RoW papers in the table.
Note: This analysis only includes Original Articles, Editorials and Review Papers
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biomedical research, in part because of their wealth and
investment in research. Irrespective of the method used to
categorize countries in developing world, (by GNP, HDI
or any other method), generation of new knowledge in
biomedical research in these nations is insufficient. In a
recent Nature paper on science publications Japan occu-
pies 4th place, Israel 15th, China 19th, and India 22nd in
the rank order of nations based on their share of top 1%
of highly cited publications. Unsurprisingly the USA and
UK occupies the two top positions [18].
There are many reasons to strive for a more just interna-
tional distribution of biomedical research in leading jour-
nals. The burden of disease in the world falls heavily on
developing countries and the pattern of this burden is
likely to change in the next twenty years. Diseases like TB,
HIV, Malaria, Dengue, and viral hemorrhagic fevers are
now no longer tropical with increase in international
travel, global warming, refugees, economic and military
intervention and conflicts. Newly emerging infections
from tropics such as SARS and bird flu can have devastat-
ing effects far away from tropics. In addition, diseases
such as diabetes and obesity can no longer be considered
as diseases in the developed world. As the impact and bur-
den of these diseases are more in developing countries
more research publications are needed from South.
Clinicians and policy makers in many developing coun-
tries have limited access to international journals because
medical libraries often need to make a choice from a
number of journals due to financial constraints. Often, it
is the high-impact journal, which is subscribed to. Thus,
the proportion of international representation in these
leading journals may be a crucial factor in influencing
health policies in many countries. The importance of
research goes well beyond its impact on health policies
[11]. Thus, research on the epidemiology and manage-
ment of diseases in different health systems raises the
probability of identifying risk factors for diseases and
identifying innovative approaches to their management.
This fact was well reflected in the multi-center eclampsia
trial [19]. Until this trial was carried out in Africa, South
America and India, the subject of using magnesium sul-
fate in the management of eclampsia was controversial.
The other good example is the only meningitis B vaccine
in the world, which was developed by the Carlos J. Finlay
Institute in Cuba and now saves lives all over the world
[20].
Providing free journals electronically to the developing
countries is a commendable step in correcting the thirst
for new information [21]. However the one-way flow of
information by making journals electronically free to
developing world is unlikely to be sufficient [22]. By pro-
viding journals free to 'RoW', and propagating research
which has been conducted in countries where only 10%
of the disease burden is experienced is itself a moral and
ethical issue.
Ultimately, we believe that strengthening the health
research capacity in developing world and providing rea-
sonable opportunities for publications arising from the
developing world are critical, not only for achieving bio-
medical research publication equity, but also advancing
medical science.
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